Woebot Health Stock

Woebot Health offers digital therapeutics to make mental health radically accessible.

Sign up today and learn more about Woebot Health Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Woebot Health Stock

Woebot Health has created relational technologies that underpin a new generation of digital therapeutics and tools for mental health. The company’s proprietary relational agent, Woebot, is capable of quickly forming a bond with users and delivering human-like therapeutic encounters that are psychologically related, responsive to a person’s dynamic state of health, and targeted using multidisciplinary tools. Woebot is at the heart of the company’s AI-powered platform and the foundation for digital therapeutics and tools that seamlessly integrate within health ecosystems and solve for gaps along the health care journey. The company is headquartered in San Francisco and is funded in part by venture capital firms New Enterprise Associates (NEA), Jazz Venture Partners L.P., Temasek, Owl Ventures, and BlackRock Private Equity Partners with participation from Andrew Ng’s AI Fund.

Funding History

March 2018$22.8M
December 2020$1.0M
July 2021$90.0M



Michael Evers


Alison Darcy

Chief Commercial and Strategy Officer

Monique Levy

Chief Clinical Officer

Athena Robinson

Chief Technology Officer

Casey Sackett

Vice President and Medical Director

Timothy Mariano, MD, PhD, MSc, Vice President and Medical Director

SVP Commercial

Sheetal Shah

Chairman of the Board

Andrew Ng


Thomas Park

Vice President of User Experience

Kim Goodwin

Managing Director

Ross A. Jaffe

Managing Partner

Andrew Firlik

General Partner and Chairman and Head, Asia

Carmen Chang


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: